Clinical trial of effects of alogliptin bensoate on endothelial function in type II diabetes mellitus
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 May 2016
At a glance
- Drugs Alogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 25 Mar 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 25 Mar 2016 Planned End Date changed from 1 Mar 2016 to 1 May 2016.
- 16 Apr 2012 New trial record